EnteroMedics (ETRM) flunks clinical trials, shares fall hard
EnteroMedics Inc. (NASDAQ: ETRM) shares plummeted 56.7% to $1.23 Friday. The company said Thursday its implanted device to treat obesity didn’t measure up in a clinical trial. Share volume was 1.5 million, overwhelming an all-day average of 95,000
Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here